Korean Market
EXCH
GC CELL
★

GC Cell Receives Approval for Amendment of Phase 1 Clinical Trial Plan for GCC2005, Adding Arms for Patient Convenience and Dose Optimization

 
OTHR
GC CELL
★

GC Cell Corporation completes disposal of 73,130 treasury shares to employees with minimal dilution impact

 
MATR
GC CELL
★

GC Cell Decides to Dispose 73,203 Treasury Shares for Employee Incentive, Minimal Dilution Impact

 
EXCH
GC CELL
★

GC Cell Files Amendment for Phase 1 Clinical Trial of GCC2005 in Relapsed or Refractory NK/T-cell Malignancies

 
PERI
GC CELL
★

GC Cell Q1 2026: Net Loss Narrowed, Pipeline and Tech Transfer on Track

 
EXCH
GC CELL
★

2026 Q1 Preliminary Results: Revenue Decline, Operating Loss Widens, Net Loss Improves